Showing results (21-30 of 117) with videos related to
Sort By:
Pageof 12
Pharmacology, Biochemistry, and Behavior|September 24, 1999
Behavioral effects of flibanserin (BIMT 17)F Borsini, A Brambilla, N Grippa, et al.The Journal of Extra-Corporeal Technology|June 10, 2000
Investigations into the sterility of manually assembled extracorporeal circuits with vented reservoirsB Searles, C E O'Leary, D Pettit, et al.European Journal of Pharmacology|June 3, 1996
Pharmacological characterization of AMPA-induced biting behaviour in miceA Brambilla, A Prudentino, N Grippa, et al.JIMD Reports|February 23, 2013
Unexplained hypoglycemia during continuous nocturnal gastric drip-feeding in a patient with glycogen storage disease type ia: is it a dumping-like syndrome?A Brambilla, A Pozzoli, F Furlan, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|March 1, 1985
Cholinergic control of gastric acid secretionF Pagani, A Brambilla, A Schiavone, et al.Pharmacological Research|February 1, 1993
The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxietyF Borsini, A Brambilla, R Cesana, et al.Annali Di Igiene : Medicina Preventiva E Di Comunita|July 5, 2021
Validation Checklist for Massive Vaccination CentersS Capolongo, A Brambilla, A Girardi, et al.The International Journal of Neuropsychopharmacology|May 10, 2001
Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in ratsF Borsini, A Brambilla, R Cesana, et al.The Journal of Pharmacy and Pharmacology|September 1, 1993
DAU 6215, a novel 5-HT3-receptor antagonist, selectively antagonizes scopolamine-induced deficit in a passive-avoidance task, but not scopolamine-induced hypermotility in ratsA Brambilla, A Ghiorzi, N Pitsikas, et al.Molecular & General Genetics : MGG|May 1, 1997
A simple signal element mediates transcription termination and mRNA 3' end formation in the DEG1 gene of Saccharomyces cerevisiaeA Brambilla, D Mainieri, M L Agostoni CarbonePageof 12